Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 39 Records) |
| Query Trace: Carcinoma in Situ and BRCA2[original query] |
|---|
| Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing. Cancer prevention research (Philadelphia, Pa.) 2010 Dec 3 (12): 1579-85. Hall Michael J, Reid Julia E, Wenstrup Richard |
| BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Dec 28 (36): 5265-73. Rijnsburger Adriana J, Obdeijn Inge-Marie, Kaas Reinoutje, Tilanus-Linthorst Madeleine M A, Boetes Carla, Loo Claudette E, Wasser Martin N J M, Bergers Elisabeth, Kok Theo, Muller Sara H, Peterse Hans, Tollenaar Rob A E M, Hoogerbrugge Nicoline, Meijer Sybren, Bartels Carina C M, Seynaeve Caroline, Hooning Maartje J, Kriege Mieke, Schmitz Paul I M, Oosterwijk Jan C, de Koning Harry J, Rutgers Emiel J T, Klijn Jan G |
| Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG : an international journal of obstetrics and gynaecology 2011 Jun 118 (7): 814-24. Manchanda R, Abdelraheim A, Johnson M, Rosenthal A N, Benjamin E, Brunell C, Burnell M, Side L, Gessler S, Saridogan E, Oram D, Jacobs I, Menon |
| Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ. Cancer 2012 Mar 118 (6): 1515-22. Bayraktar Soley, Elsayegh Nisreen, Gutierrez Barrera Angelica M, Lin Heather, Kuerer Henry, Tasbas Tunc, Muse Kimberly I, Ready Kaylene, Litton Jennifer, Meric-Bernstam Funda, Hortobagyi Gabriel N, Albarracin Constance T, Arun Ba |
| Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012 Sep 21 (9): 1458-68. Heijnsdijk Eveline A M, Warner Ellen, Gilbert Fiona J, Tilanus-Linthorst Madeleine M A, Evans Gareth, Causer Petrina A, Eeles Rosalind A, Kaas Reinie, Draisma Gerrit, Ramsay Elizabeth A, Warren Ruth M L, Hill Kimberly A, Hoogerbrugge Nicoline, Wasser Martin N J M, Bergers Elisabeth, Oosterwijk Jan C, Hooning Maartje J, Rutgers Emiel J T, Klijn Jan G M, Plewes Don B, Leach Martin O, de Koning Harry |
| The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 2012 Nov . Mazzola E, Cheng SC, Parmigiani G |
| Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria. Clinical genetics 2014 Jan 85 (1): 72-5. Singer C F, Muhr D, Rappaport C, Tea M-K, Gschwantler-Kaulich D, Fink-Retter A, Pfeiler G, Berger A, Sun P, Narod S |
| Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal. Clinical genetics 2014 Jan 85 (1): 31-5. Ghadirian P, Robidoux A, Nassif E, Martin G, Potvin C, Patocskai E, Younan R, Larouche N, Venne A, Zhang S, Royer R, Narod S |
| HIF-1a overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers. PloS one 2013 8 (2): e56055. van der Groep Petra, van Diest Paul J, Smolders Yvonne H C M, Ausems Margreet G E M, van der Luijt Rob B, Menko Fred H, Bart Joost, de Vries Elisabeth G E, van der Wall Elsk |
| Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry. Journal of breast cancer 2014 Jun 17 (2): 129-35. Yu Jong-Han, Lee Jong Won, Son Byung Ho, Kim Sung-Won, Park Sue K, Lee Min Hyuk, Kim Lee Su, Noh Woo-Chul, Kim Eun-Kyu, Yoon Dae Sung, Lee Jeeyeon, Jung Jin Hyang, Jung Sang Seol, Gong Gyungyup, Ahn Sei-Hy |
| Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2. Cancer 2014 May 120 (10): 1557-64. Jackson Sarah A, Davis Andrew A, Li Jun, Yi Nengjun, McCormick Shelley R, Grant Carly, Fallen Taya, Crawford Beth, Loranger Kate, Litton Jennifer, Arun Banu, Vande Wydeven Kimberly, Sidani Amer, Farmer Katie, Sanders Merideth, Hoskins Kent, Nussbaum Robert, Esserman Laura, Garber Judy E, Kaklamani Virginia G, |
| BRCA2 carriers with male breast cancer show elevated tumour methylation. BMC cancer 2017 9 17 (1): 641. Deb Siddhartha, Gorringe Kylie L, Pang Jia-Min B, Byrne David J, Takano Elena A, , Dobrovic Alexander, Fox Stephen |
| Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance. Annals of surgical oncology 2017 8 24 (10): 3048-3054. Gilbert Elizabeth, Zabor Emily C, Stempel Michelle, Mangino Debra, Heerdt Alexandra, Pilewskie Melis |
| Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 2017 Mar . Krammer Julia, Pinker-Domenig Katja, Robson Mark E, Gönen Mithat, Bernard-Davila Blanca, Morris Elizabeth A, Mangino Debra A, Jochelson Maxine |
| Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan. Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 2017 1 16 (3): 265-269. Tozaki Mitsuhiro, Nakamura Seigo, Kitagawa Dai, Iwase Takuji, Horii Rie, Akiyama Futoshi, Arai Masa |
| Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug . Guindalini Rodrigo Santa Cruz, Zheng Yonglan, Abe Hiroyuki, Whitaker Kristen, Yoshimatsu Toshio F, Walsh Tom, Schacht David, Kulkarni Kirti, Sheth Deepa, Verp Marion S, Bradbury Angela R, Churpek Jane, Obeid Elias, Mueller Jeffrey, Khramtsova Galina, Liu Fang, Raoul Akila, Cao Hongyuan, Romero Iris L, Hong Susan, Livingston Robert, Jaskowiak Nora, Wang Xiaoming, Debiasi Marcio, Pritchard Colin C, King Mary-Claire, Karczmar Gregory, Newstead Gillian M, Huo Dezheng, Olopade Olufunmilayo |
| Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic. Clinical breast cancer 2018 08 18 (4): e695-e698. Laitman Yael, Feldman Dana Madorsky, Sklair-Levy Miri, Yosepovich Ady, Barshack-Nakar Iris, Brodsky Malka, Halshtok Osnat, Shalmon Anat, Gotlieb Michael, Friedman Eit |
| Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. Nature communications 2019 9 10 (1): 4182. Ding Lina, Su Ying, Fassl Anne, Hinohara Kunihiko, Qiu Xintao, Harper Nicholas W, Huh Sung Jin, Bloushtain-Qimron Noga, Jovanovi? Bojana, Ekram Muhammad, Zi Xiaoyuan, Hines William C, Ale?kovi? Maša, Gil Del Alcazar Carlos, Caulfield Ryan J, Bonal Dennis M, Nguyen Quang-De, Merino Vanessa F, Choudhury Sibgat, Ethington Gabrielle, Panos Laura, Grant Michael, Herlihy William, Au Alfred, Rosson Gedge D, Argani Pedram, Richardson Andrea L, Dillon Deborah, Allred D Craig, Babski Kirsten, Kim Elizabeth Min Hui, McDonnell Charles H, Wagner Jon, Rowberry Ron, Bobolis Kristie, Kleer Celina G, Hwang E Shelley, Blum Joanne L, Cristea Simona, Sicinski Piotr, Fan Rong, Long Henry W, Sukumar Saraswati, Park So Yeon, Garber Judy E, Bissell Mina, Yao Jun, Polyak Kornel |
| Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Jul 28 (7): 1162-1168. Petridis Christos, Arora Iteeka, Shah Vandna, Moss Charlotte L, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
| Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50?years. Breast cancer research : BCR 2019 May 21 (1): 58. Petridis Christos, Arora Iteeka, Shah Vandna, Megalios Anargyros, Moss Charlotte, Mera Anca, Clifford Angela, Gillett Cheryl, Pinder Sarah E, Tomlinson Ian, Roylance Rebecca, Simpson Michael A, Sawyer Elinor |
| BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ. Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
| High risk of breast cancer in women with biallelic pathogenic variants in CHEK2. Breast cancer research and treatment 2020 1 180 (2): 503-509. Rainville Irene, Hatcher Shanell, Rosenthal Eric, Larson Katie, Bernhisel Ryan, Meek Stephanie, Gorringe Heidi, Mundt Erin, Manley Sus |
| High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer. Journal of medical genetics 2021 3 59 (2): 115-121. Evans D Gareth, van Veen Elke Maria, Byers Helen J, Evans Sarah J, Burghel George J, Woodward Emma Roisin, Harkness Elaine F, Eccles Diana M, Greville-Haygate Stephanie L, Ellingford Jamie M, Bowers Naomi L, Pereira Marta, Wallace Andrew J, Howell Sasha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam Ja |
| Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers. The breast journal 2022 11 2022 4317693. Faermann Renata, Friedman Eitan, Kaidar-Person Orit, Weidenfeld Jonathan, Brodsky Malka, Shalmon Anat, Halshtok Neiman Osnat, Gotlieb Michael, Yagil Yael, Samoocha David, Madorsky Feldman Dana, Sklair-Levy Mi |
| Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers. Journal of medical genetics 2022 11 . Evans D Gareth, Sithambaram Siva, van Veen Elke Maria, Burghel George J, Schlecht Helene, Harkness Elaine F, Byers Helen, Ellingford Jamie M, Gandhi Ashu, Howell Sacha J, Howell Anthony, Forde Claire, Lalloo Fiona, Newman William G, Smith Miriam Jane, Woodward Emma Rois |
| Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial). BMC cancer 2023 9 23 (1): 865. Sung-Hsin Kuo, Ling-Ming Tseng, Shou-Tung Chen, Yasuaki Sagara, Yuan-Ching Chang, Hsien-Tang Yeh, Yao-Lung Kuo, Chih-Chiang Hung, Tzu-Pin Lu, Yi-Hsuan Lee, Masakazu Toi, Chiun-Sheng Hua |
| Characterization of patients with a diagnosis of breast cancer and melanoma: genetic susceptibility or increased surveillance? European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023 3 . Jia Karen Y, Menes Tehillah S, Bernstein-Molho Rinat, Nissan Aviram, Zippel D |
| Clinicopathological and imaging features of ductal carcinoma in situ in BRCA1/2 mutation carriers. Breast disease 2023 2 42 (1): 5-15. Seki Akina, Tsunoda Hiroko, Takei Junko, Suzuki Misato, Kanomata Naoki, Yamauchi Hide |
| Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience. Hereditary cancer in clinical practice 2023 11 21 (1): 23. Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagaya |
| The Pathological Pattern of Breast Cancer in the Najran Region of Saudi Arabia: A Retrospective Study. Cureus 2024 8 16 (8): e67621. Abdulrahman M Alamri, Hajar H AlWadai, Saad M Almowallad, Saleh M AlKulayb, Zahra E Abdalwahab, Shuruq M Alzahuf, Saleh H Alshaib |
- Page last reviewed:Feb 1, 2024
- Content source: